Andrew Hamer
Chief Tech/Sci/R&D Officer at CARDIOL THERAPEUTICS INC.
Net worth: 440 459 $ as of 30/04/2024
Profile
Andrew Hamer is currently the Chief Medical Officer and Head of Research & Development at Cardiol Therapeutics, Inc. Prior to this, he worked at Amgen, Inc. as the Executive Director of Global Development from 2018 to 2021.
He also held the position of Vice President of Medical Affairs at Capricor, Inc. and Capricor Therapeutics, Inc. from 2013 to 2015.
Dr. Hamer completed his undergraduate degree at the University of Otago.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 29/02/2024 | 239,380 ( 0.35% ) | 440 459 $ | 30/04/2024 |
Andrew Hamer active positions
| Companies | Position | Start |
|---|---|---|
| CARDIOL THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 29/03/2021 |
Former positions of Andrew Hamer
| Companies | Position | End |
|---|---|---|
| AMGEN INC. | Corporate Officer/Principal | 01/03/2021 |
| CAPRICOR THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 30/07/2015 |
Capricor, Inc.
 Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013. | Chief Tech/Sci/R&D Officer | - |
Training of Andrew Hamer
| University of Otago | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| CAPRICOR THERAPEUTICS, INC. | Health Technology |
| CARDIOL THERAPEUTICS INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Private companies | 1 |
|---|---|
Capricor, Inc.
Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013. | Health Technology |
- Stock Market
- Insiders
- Andrew Hamer